Exhibit 99.2

XENITH BANKSHARES, INC.

CONSOLIDATED BALANCE SHEETS

As of September 30, 2017 and December 31, 2016

 

(unaudited)        
(in thousands, except share data)  September 30, 2017   December 31, 2016 
Assets        
Cash and due from banks  $14,960   $18,825 
Interest-bearing deposits in other banks   13,398    4,797 
Overnight funds sold and due from Federal Reserve Bank   136,795    103,372 
Investment securities available for sale, at fair value   305,768    317,443 
Restricted equity securities, at cost   22,044    24,313 
Loans held for sale   19,397     
Loans   2,424,140    2,464,056 
Allowance for loan losses   (16,265)   (21,940)
Net loans   2,407,875    2,442,116 
Premises and equipment, net   55,178    56,996 
Interest receivable   8,673    8,806 
Other real estate owned and repossessed assets, net of valuation allowance   4,817    5,345 
Goodwill   26,931    26,931 
Core deposit intangible, net   3,393    3,787 
Net deferred tax assets, net of valuation allowance   148,425    157,825 
Bank-owned life insurance   73,431    72,104 
Other assets   14,686    13,969 
Assets of discontinued operations       10,563 
Totals assets  $3,255,771   $3,267,192 
Liabilities and Shareholders' Equity          
Deposits:          
Noninterest-bearing demand  $541,275   $501,678 
Interest-bearing:          
Demand and money market   1,187,551    1,113,453 
Savings   95,053    86,739 
Time deposits less than $250   713,527    785,303 
Time deposits $250 or more   67,984    84,797 
Total deposits   2,605,390    2,571,970 
Federal Home Loan Bank borrowings   105,000    172,000 
Other borrowings   39,197    38,813 
Interest payable   812    829 
Other liabilities   20,439    19,093 
Liabilities of discontinued operations   672    849 
Total liabilities   2,771,510    2,803,554 
Commitments and contingencies          
Shareholders' equity:          
Preferred stock, 1,000,000 shares authorized; none issued and outstanding        
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 23,215,318 and 23,123,518 shares issued and outstanding on September 30, 2017 and December 31, 2016, respectively   232    231 
Capital surplus   711,377    710,916 
Accumulated deficit   (226,252)   (245,538)
Accumulated other comprehensive loss, net of tax   (1,096)   (2,428)
Total shareholders' equity before non-controlling interest   484,261    463,181 
Non-controlling interest of discontinued operations       457 
Total shareholders' equity   484,261    463,638 
Total liabilities and shareholders' equity  $3,255,771   $3,267,192 

 

See accompanying notes to unaudited consolidated financial statements.

 

 1 

 

 

CONSOLIDATED STATEMENTS OF INCOME

For the Three and Nine Months Ended September 30, 2017 and 2016

 

(unaudited)

  Three Months Ended   Nine Months Ended 
(in thousands)  September 30,
2017
   September 30,
2016
   September 30,
2017
   September 30,
2016
 
Interest Income                    
Loans, including fees  $28,168   $25,513   $82,676   $58,797 
Investment securities   1,986    1,763    6,251    4,476 
Overnight funds sold and deposits in other banks   258    96    734    179 
Total interest income   30,412    27,372    89,661    63,452 
Interest Expense                    
Deposits:                    
Demand and money market   1,822    1,391    5,082    3,075 
Savings   63    40    180    81 
Time deposits   2,265    2,169    6,890    5,746 
Interest expense on deposits   4,150    3,600    12,152    8,902 
Federal Home Loan Bank borrowings   299    109    594    109 
Other borrowings   738    652    2,128    1,706 
Total interest expense   5,187    4,361    14,874    10,717 
Net interest income   25,225    23,011    74,787    52,735 
Provision for loan losses       10,685    9    10,704 
Net interest income after provision for loan losses   25,225    12,326    74,778    42,031 
Noninterest Income                    
Service charges on deposit accounts   1,258    1,191    3,561    3,447 
Earnings from bank-owned life insurance   426    395    1,327    1,046 
Gain on sale of loans           38     
Net gain on sale of investment securities available for sale   977        977    15 
Visa check card income   806    709    2,399    2,056 
Other   705    575    2,822    1,430 
Total noninterest income   4,172    2,870    11,124    7,994 
Noninterest Expense                    
Salaries and employee benefits   9,914    9,880    30,186    24,990 
Professional and consultant fees   830    978    2,792    2,101 
Occupancy   1,802    1,594    5,586    4,428 
FDIC insurance   349    679    1,498    1,524 
Data processing and technology   1,367    1,446    3,909    3,985 
Problem loan and repossessed asset costs   (1)   219    306    420 
Impairments on and (gains) and losses from sales of other real estate owned and repossessed assets   (48)   685    63    112 
Equipment   322    309    1,049    812 
Board fees   350    493    596    1,133 
Advertising and marketing   158    398    667    503 
Merger-related   930    12,910    2,895    15,555 
Other   2,806    2,944    8,202    6,854 
Total noninterest expense   18,779    32,535    57,749    62,417 
Income (loss) from continuing operations before provision (benefit) for income taxes   10,618    (17,339)   28,153    (12,392)
Provision (benefit) for income taxes - continuing operations   3,453    (64,840)   8,997    (62,794)
Net income from continuing operations   7,165    47,501    19,156    50,402 
Net (loss) income from discontinued operations before (benefit) provision for income taxes   (26)   2,011    (262)   3,900 
(Benefit) provision for income taxes - discontinued operations   (5)   842    (65)   877 
Net (loss) income from discontinued operations attributable to non-controlling interest   (14)   806    (129)   1,556 
Net (loss) income from discontinued operations   (7)   363    (68)   1,467 
Net income attributable to Xenith Bankshares, Inc.  $7,158   $47,864   $19,088   $51,869 

 

See accompanying notes to unaudited consolidated financial statements.

 

 2 

 

  

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three and Nine Months Ended September 30, 2017 and 2016

 

(unaudited)

  Three Months Ended   Nine Months Ended 
(in thousands)  September 30,
2017
   September 30,
2016
   September 30,
2017
   September 30,
2016
 
Net income attributable to Xenith Bankshares, Inc.  $7,158   $47,864   $19,088   $51,869 
Other comprehensive income, net of tax:                    
Change in net unrealized gain on securities available for sale   339    475    3,026   $4,178 
Income tax effect   (119)       (1,059)   (1,340)
Reclassification adjustment for net gain on sale of investment securities included in net income   (977)       (977)   (15)
Income tax effect   342        342    5 
Other comprehensive income, net of tax   (415)   475    1,332    2,828 
Comprehensive income attributable to Xenith Bankshares, Inc.  $6,743   $48,339   $20,420   $54,697 

 

 3 

 

  

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

For the Nine Months Ended September 30, 2017

 

                   Accumulated
Other
         
(unaudited)  Common Stock   Capital   Accumulated   Comprehensive
Income (Loss),
   Non-
controlling
   Total
Shareholders'
 
(in thousands, except share data)  Shares   Amount   Surplus   Deficit   Net of Tax   Interest   Equity 
Balance at December 31, 2016   23,123,518   $231   $710,916   $(245,538)  $(2,428)  $457   $463,638 
Net income               19,088        (129)   18,959 
Other comprehensive income, net of tax                   1,332        1,332 
Share-based compensation expense           1,530                1,530 
Net settlement of restricted stock awards   36,824        (163)               (163)
Restricted stock awards issued under incentive plan           236                 236 
Restricted stock awards granted   14,823                         
Forfeiture of restricted stock awards   (404)                        
Net exercises of stock options   40,557    1    529                530 
Reclassification to other liabilities                       (328)   (328)
Cumulative effect adjustment of adoption of accounting principle               198            198 
Repurchase of U.S. Treasury warrant      $   $(1,671)  $   $   $    (1,671)
Balance at September 30, 2017   23,215,318   $232   $711,377   $(226,252)  $(1,096)  $   $484,261 

 

See accompanying notes to unaudited consolidated financial statements.

 

 4 

 

  

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30, 2017 and 2016

 

(unaudited)  Nine Months Ended 
(in thousands)  September 30, 2017   September 30, 2016 
Cash flows from operating activities          
Net income from continuing operations  $19,156   $50,402 
Adjustments to reconcile net income to net cash used in operating activities:          
Depreciation and amortization   2,172    2,146 
Deferred income tax expense   8,997    (67,536)
Accretion and amortization of fair value adjustments   (2,246)   (798)
Amortization of core deposit intangible   394     
Provision for loan losses   9    10,704 
Share-based compensation expense   1,530    1,532 
Net amortization of premiums and accretion of discounts on investment securities available for sale   4,587    1,541 
Unrealized (gain) loss on investment securities available for sale   (2,049)    
Earnings from bank-owned life insurance   (1,327)   (1,046)
Gain on sale of investment securities available for sale   (977)   (15)
Impairments on and gains and losses from sales of other real estate owned and repossessed assets   63    56 
Impairments on and gains and losses from sales of premises and equipment   (15)   41 
Gain on sale of loans   (38)    
Changes in:          
Interest receivable   133    (625)
Other assets   (768)   10,883 
Interest payable   (17)   (103)
Other liabilities   1,418    (37,483)
Net cash provided by operating activities - continuing operations   31,022    (30,301)
Net cash provided by operating activities - discontinued operations   9,796    1,835 
Cash provided by operating activities   40,818    (28,466)
Cash flows from investing activities          
Cash acquired in acquisition       69,241 
Proceeds from maturities and calls of investment securities available for sale   34,202    27,002 
Proceeds from sale of investment securities available for sale   34,473    31,632 
Purchase of investment securities available for sale   (56,512)   (46,943)
Proceeds from sale of restricted equity securities   18,573    11,317 
Purchase of restricted equity securities   (16,303)   (25,962)
Proceeds from sale of guaranteed student loans   20,000     
Net decrease (increase) in loans   (3,801)   (107,841)
Proceeds from sale of other real estate owned and repossessed assets, net   1,769    12,078 
Purchases of premises and equipment, net   (339)   (1,788)
Net cash provided by (used in) investing activities - continuing operations   32,062    (31,264)
Net cash (used in) investing activities - discontinued operations       1,473 
Cash provided by (used in) investing activities   32,062    (29,791)
Cash flows from financing activities          
Net increase (decrease) in deposits   33,420    (74,615)
Net (decrease) increase in short-term Federal Home Loan Bank borrowings   (67,000)   172,500 
Repayments of long term Federal Home Loan Bank borrowings        
Net increase in other borrowings       8,405 
Issuance of common stock related to bank acquisition        
Proceeds from exercise of stock options   530    26 
Repurchase of common stock in the settlement of restricted stock units       (970)
Repurchase of treasury warrants   (1,671)    
Cash consideration paid in acquisition       (1)
Reclassification to other liabilities        
Distributed non-controlling interest       (925)
Net cash (used in) provided by financing activities   (34,721)   104,420 
Increase in cash and cash equivalents   38,159    46,163 
Cash and cash equivalents at beginning of period   126,994    63,746 
Cash and cash equivalents at end of period  $165,153   $109,909 
Supplemental cash flow information:          
Cash paid for interest  $14,870   $10,140 
Cash paid for income taxes  $   $79 
Supplemental non-cash information:          
   Change in unrealized gain on investment securities available for sale, net of tax  $1,332   $2,828 
   Transfer from other real estate owned and repossessed assets to loans  $   $1,194 
   Transfer from loans to other real estate owned and repossessed assets  $1,304   $5,003 
   Transfer from premises and equipment to other real estate owned and repossessed assets       734 
Non-cash transaction related to the Merger          
Assets acquired       1,094,987 
Liabilities assumed       1,002,793 

 

See accompanying notes to unaudited consolidated financial statements.

 

 5 

 

  

NOTE 1 - Basis of Presentation

 

Xenith Bankshares, Inc. ("Xenith Bankshares" or the "Company") is the bank holding company for Xenith Bank (the "Bank"), a Virginia-based institution headquartered in Richmond, Virginia. As of September 30, 2017, the Company, through the Bank, operated 40 full-service branches and two loan production offices. Xenith Bank is a commercial bank specifically targeting the banking needs of middle market and small business, local real estate developers and investors, and retail banking clients. The Bank offers marine finance floorplan and end-user loans through its Shore Premier Finance unit. Xenith Bank's regional area of operations spans from Baltimore, Maryland, to Raleigh and eastern North Carolina, complementing its significant presence in greater Washington, D.C., greater Richmond, Virginia, and greater Hampton Roads, Virginia.

 

On May 19, 2017, the Company and Union Bankshares Corporation ("Union") entered into of an Agreement and Plan of Reorganization (the "Union Merger Agreement"), pursuant to which, and subject to terms and conditions set forth therein, Xenith Bankshares will merge with and into Union (the "Union Merger"), with Union surviving in the Union Merger. Pursuant to the Union Merger Agreement at the effective time of the Union Merger, holders of Xenith Bankshares' common stock will receive the right to 0.9354 shares of Union common stock in exchange for each share of the common stock outstanding at the effective time of the Union Merger, with cash paid in lieu of fractional shares.

 

The Company and Union have received regulatory approval for the Union Merger from the Federal Reserve Bank of Richmond and the Virginia State Corporation Commission. In addition, the shareholders of both the Company and Union have approved the Union Merger. The completion of the Union Merger is subject to certain normal and customary closing conditions, and it is currently anticipated that the closing of the Union Merger will occur during early January 2018.

 

Effective July 29, 2016, the Company (previously, Hampton Roads Bankshares, Inc.) completed its merger (the "Legacy Xenith Merger") with legacy Xenith Bankshares, Inc. ("Legacy Xenith"), pursuant to an Agreement and Plan of Reorganization (the "Legacy Xenith Merger Agreement"), dated as of February 10, 2016, by and between the Company and Legacy Xenith. At the effective time of the Legacy Xenith Merger, Legacy Xenith merged with and into the Company, with the Company surviving the Legacy Xenith Merger. Also at the effective time of the Legacy Xenith Merger, the Company changed its name from "Hampton Roads Bankshares, Inc." to "Xenith Bankshares, Inc." and changed its ticker symbol to "XBKS."

 

Pursuant to the Legacy Xenith Merger Agreement, holders of Legacy Xenith common stock, par value $1.00 per share, received 4.4 shares of common stock of the Company, par value $0.01 per share (the "common stock"), for each share of Legacy Xenith common stock held immediately prior to the effective time of the Legacy Xenith Merger, with cash paid in lieu of fractional shares.

 

Pursuant to the Legacy Xenith Merger Agreement and immediately following the completion of the Legacy Xenith Merger, legacy Xenith Bank, a Virginia banking corporation and wholly-owned subsidiary of Legacy Xenith, merged (the "Bank Merger") with and into the Bank, with the Bank surviving the Bank Merger. In connection with the Bank Merger, the Bank changed its name from "The Bank of Hampton Roads" to "Xenith Bank."

 

Unless otherwise stated herein or the context otherwise requires, references herein to "the Company" prior to the effective time of the Legacy Xenith Merger are to Hampton Roads Bankshares, Inc. and its wholly-owned subsidiaries, and references to "the Bank" are to The Bank of Hampton Roads. Unless otherwise stated herein or the context otherwise requires, references herein to "the Company" after the effective time of the Legacy Xenith Merger are to Xenith Bankshares, Inc. (f/k/a Hampton Roads Bankshares, Inc.) and its wholly-owned subsidiaries, and references to "the Bank" are to Xenith Bank (f/k/a The Bank of Hampton Roads). Information presented herein as of and for the three- and nine-month periods ended September 30, 2016 includes the operations of Legacy Xenith for the period since the effective time of the Legacy Xenith Merger, July 29, 2016.

 

 6 

 

  

In September 2016, the Company decided to cease operations of its mortgage banking business. In connection with this decision, the Bank entered into a definitive asset purchase agreement to sell certain assets of Gateway Bank Mortgage, Inc., a wholly-owned subsidiary of the Bank ("GBMI"), and to transition GBMI's operations, which included originating, closing, funding and selling first lien residential mortgage loans, to an unrelated party (the "GBMI Sale"). The completion of the GBMI Sale occurred on October 17, 2016. The operations of GBMI have been reported as discontinued operations for all periods presented herein.

 

On December 13, 2016 a reverse stock split of the Company's outstanding shares of common stock at a ratio of 1-for-10 (the "Reverse Stock Split"), which had been previously approved by the Company's shareholders, became effective. No fractional shares were issued in the Reverse Stock Split, rather shareholders of fractional shares received a cash payment based on the closing price of the common stock as of the date of the Reverse Stock Split. The par value of each share of common stock remained unchanged at $0.01 per share and the number of authorized shares was not affected. References made to outstanding shares or per share amounts in the accompanying consolidated financial statements and disclosures have been retroactively adjusted to reflect the Reverse Stock Split, unless otherwise noted.

 

In December 2008, the Company entered into a Letter Agreement and Securities Purchase Agreement – Standard Terms with the United States Department of the Treasury (the “Treasury”), pursuant to which the Treasury purchased (i) shares of the Company’s preferred stock and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant”). On September 13, 2017, the Company repurchased the Warrant from the Treasury for an aggregate cash purchase price of $1.7 million, the fair market value of the Warrant as agreed upon by the Company and the Treasury, and canceled the Warrant. Following the Company’s repurchase of the Warrant, the Treasury has no remaining equity interest in the Company.

 

The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial reporting and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the financial statements reflect all adjustments (consisting of a normal recurring nature) considered necessary for a fair presentation. The results of operations for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year. The Company has one banking subsidiary, the Bank, which constitutes substantially all of the Company's assets and operations.

 

Certain comparative balances have been reclassified to reflect current presentation. Any reclassification had no effect on total assets, total shareholders' equity or net income. All dollar amounts included in the tables in these notes are in thousands, except per share data, unless otherwise stated.

 

For further information, refer to the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make assumptions, judgments and estimates that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term are the determination of the allowance for loan losses, the valuation of other real estate owned and repossessed assets, the valuation of net deferred tax assets, the determination of fair value for financial instruments, and the determination of fair values of loans and other assets acquired and liabilities assumed in the Legacy Xenith Merger.

 

 7 

 

  

Recent Accounting Pronouncements

 

During the second quarter of 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"). ASU 2014-09 represents a comprehensive reform of many of the revenue recognition requirements in GAAP. ASU 2014-09 creates a new topic Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC 606"). ASC 606 will supersede the current revenue recognition requirements in ASC 605, Revenue Recognition, and will supersede or amend much of the industry-specific revenue recognition guidance found throughout the ASC. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 creates a five-step process for achieving that core principle: (1) identifying the contract with the customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations; and (5) recognizing revenue when an entity has completed the performance obligations. ASC 606 also requires additional disclosures that allow users of the financial statements to understand the nature, timing and uncertainty of revenue and cash flows resulting from contracts with customers. The effective date of ASC 606 is for the year beginning January 1, 2018. The new revenue standard permits the use of retrospective or cumulative effect transition methods. The Company has evaluated those revenue types that are specifically excluded from the application of ASC 606, including the majority of the Company's contracts with customers (i.e., financial instruments), and does not expect the adoption of this standard to have a material effect on the Company's consolidated financial statements.

 

In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting ("ASU 2016-09"), which is intended to improve the accounting for share-based payment transactions as part of the FASB's simplification initiative. ASU 2016-09 changes seven aspects of the accounting for share-based payment award transactions, including: (1) accounting for income taxes; (2) classification of excess tax benefits on the statement of cash flows; (3) forfeitures; (4) minimum statutory tax withholding requirements; (5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes; (6) practical expedient - expected term (nonpublic entities only); and (7) intrinsic value (nonpublic entities only). ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within those years.

 

In accordance with ASU 2016-09, and beginning in 2017, the Company recognizes excess tax benefits and tax deficiencies as income tax benefit or expense, respectively, in the reporting period in which they occur. Prior to the adoption of this standard, the Company recognized excess tax benefits as capital surplus only when the amounts reduced taxes payable. The adoption of the standard resulted in a cumulative effect adjustment to accumulated deficit of $198 thousand, which represents the amount of excess tax benefits that had not been previously recognized due to the Company's net operating loss position.

 

In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business ("ASU 2017-01"), which provides a new framework for determining whether transactions should be accounted for as acquisitions or dispositions of assets or businesses. ASU 2017-01 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Entities may early adopt ASU 2017-01 and apply it to transactions that have not been reported in financial statements that have been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements.

 

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment ("ASU 2017-04"), which requires an entity to no longer perform a hypothetical purchase price allocation to measure goodwill impairment. Instead, impairment will be measured using the difference between the carrying amount and the fair value of the reporting unit. ASU 2017-04 is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Entities may early adopt the standard for goodwill impairment tests with measurement dates after January 1, 2017. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements.

 

 8 

 

  

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting ("ASU 2017-09"), which clarifies what constitutes a modification of a share-based payment award. ASU 2017-09 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements.

 

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities ("ASU 2017-12"), which changes the recognition and presentation requirements of hedge accounting, including eliminating the requirement to separately measure and report hedge ineffectiveness and presenting all items that affect earnings in the same income statement line as the hedged item. The ASU also provides new alternatives for applying hedge accounting to additional hedging strategies, measuring the hedged items in fair value hedges of interest rate risk, reducing the cost and complexity of applying hedge accounting by easing the requirements for effectiveness testing, hedge documentation and application of the critical terms match method, and reducing the risk of material error correction if a company applies the shortcut method inappropriately. ASU 2017-12 is effective for annual and interim periods in fiscal years beginning after December 15, 2018. The Company has not begun its evaluation of the effect this standard will have on its consolidated financial statements.

 

 9 

 

 

 

NOTE 2 - Business Combination

 

The Company has accounted for the Legacy Xenith Merger under the acquisition method of accounting, in accordance with ASC Topic 805, Business Combinations, whereby the acquired assets and assumed liabilities are recorded by the Company at their estimated fair values as of the effective date of the Legacy Xenith Merger, which was July 29, 2016.

 

The Legacy Xenith Merger combined two banks with complementary capabilities and geographical focus, therefore providing the opportunity for the organization to leverage its existing infrastructure, including people, processes and systems, across a larger asset base.

 

In accordance with the framework established by ASC Topic 820, Fair Value Measurements and Disclosure, the Company used a fair value hierarchy to prioritize the information used to form assumptions and estimates in determining fair values. These fair value hierarchies are further discussed in "Note 14 - Fair Value Measurements" in these consolidated financial statements.

 

The following table presents the summary unaudited balance sheet of Legacy Xenith as of the date of the Legacy Xenith Merger inclusive of the estimated fair value adjustments and the allocation of consideration paid in the Legacy Xenith Merger to the acquired assets and assumed liabilities. The allocation resulted in goodwill of $26.9 million, which represents the growth opportunities and franchise value the Bank has in the markets it serves.

 

 10 

 

  

Fair value of assets acquired:    
Cash and cash equivalents  $69,241 
Securities   139,025 
Loans   827,987 
Premises and equipment   6,180 
Other real estate owned   738 
Core deposit intangible   4,006 
Accrued interest receivable   4,464 
Deferred tax asset   5,156 
Bank owned life insurance   19,917 
Other assets   17,879 
Total assets  $1,094,593 
Fair value of liabilities assumed:     
Deposits  $956,078 
Accrued interest payable   285 
Supplemental executive retirement plan   2,162 
 Borrowings   36,533 
Other liabilities   8,112 
Total liabilities  $1,003,170 
Net identifiable assets acquired  $91,423 
      
Consideration paid:     
Company's common shares issued (1)   58,915,439 
Purchase price per share (2)  $1.97 
Value of common stock issued  $116,063 
Estimated fair value of stock options   2,290 
Cash in lieu of fractional shares   1 
Total consideration paid   118,354 
Goodwill  $26,931 

 

 

(1) The issuance of shares of common stock in the Legacy Xenith Merger preceded the Reverse Stock Split and the number of shares of common stock is presented on a pre-Reverse Stock Split basis.

(2) The value of the shares of common stock exchanged for shares of Legacy Xenith common stock was based upon the closing price of common stock at July 28, 2016, the last trading day prior to the date of completion of the Legacy Xenith Merger.

 

The following table presents the purchased performing and purchased impaired loans receivable at the date of the Legacy Xenith Merger and the fair value adjustments recorded immediately following the Legacy Xenith Merger:

 

   Purchased Performing   Purchased Impaired   Total 
Principal payments receivable  $830,613   $9,851   $840,464 
Fair value adjustment - credit and interest   (9,318)   (3,159)   (12,477)
Fair value of acquired loans  $821,295   $6,692   $827,987 

 

 11 

 

  

NOTE 3 - Discontinued Operations

 

In connection with the GBMI Sale, GBMI ceased taking new mortgage loan applications, and all applications with prospective borrowers that were in process at the completion of the GBMI Sale were managed by GBMI through funding and sale to investors in the ordinary course of business. The decision to exit the mortgage business was based on a number of factors, including the costs of regulatory compliance and the scale required to be competitive. Proceeds from the GBMI Sale, which included the sale of certain fixed assets, were $87 thousand.

 

As of December 31, 2016, there were no remaining loans to be funded and $9.9 million of loans related to GMBI were held for sale to investors, which are included in assets from discontinued operations in the Company's consolidated balance sheet as of December 31, 2016. As of the end of the first quarter of 2017, the operations of GBMI had been transitioned to the purchaser and there were no remaining loans held for sale and no assets remaining related to GBMI. Management believes, as of September 30, 2017, there are no significant on-going obligations with respect to the mortgage banking business that have not been recorded in the Company's consolidated financial statements. As of September 30, 2017, the Company had a liability of $672 thousand recorded as liabilities of discontinued operations on its consolidated balance sheets, which is a reserve for any future obligations.

 

The following table presents summarized operating results of the discontinued operations for the period stated:

 

   Three Months Ended   Nine Months Ended 
   September 30,
2017
   September 30,
2016
   September 30,
2017
   September 30,
2016
 
Net interest income  $7   $133   $11   $440 
Provision for loan losses       (3)   (5)   (22)
Net interest income after provision for loan losses   7    136    16    462 
Noninterest income       6,760    164    16,987 
Noninterest expense:                    
Salaries and employee benefits   (1)   3,901    247    10,368 
Professional and consultant fees        73    5    204 
Occupancy   2    176    7    590 
Data processing       146    51    371 
Equipment   10    13    2    56 
Advertising and marketing       137    6    568 
Other   22    439    124    1,392 
Total noninterest expense   33    4,885    442    13,549 
Net (loss) income before provision for income taxes   (26)   2,011    (262)   3,900 
(Benefit) provision for income taxes   (5)   842    (65)   877 
Net (loss) income   (21)   1,169    (197)   3,023 
Net (loss) income attributable to non-controlling interest   (14)   806    (129)   1,556 
Net (loss) income attributable to Xenith Bankshares, Inc.  $(7)  $363   $(68)  $1,467 

 

NOTE 4 - Cash Reserves

 

To comply with regulations of the Board of Governors of the Federal Reserve System (the "Federal Reserve"), the Bank is required to maintain certain average cash reserve balances. The daily average cash reserve requirements for the periods closest to September 30, 2017 and December 31, 2016 were $62.9 million and $63.9 million, respectively. The Bank was in compliance with these requirements at September 30, 2017 and December 31, 2016.

 

 12 

 

  

NOTE 5 - Investment Securities

 

The following table presents amortized cost, gross unrealized gains and losses, and fair values of investment securities available for sale as of the dates stated:

   September 30, 2017 
       Gross   Gross     
       Unrealized   Unrealized     
   Amortized Cost   Gains   Losses   Fair Value 
Mortgage-backed securities                    
Agencies  $127,298   $450   $495   $127,253 
Collateralized   63,716    68    800    62,984 
Collateralized mortgage obligations   27,194    41    176    27,059 
Asset-backed securities   6,686        75    6,611 
Municipals                    
  Tax-exempt   63,486    32    719    62,799 
  Taxable   17,958        277    17,681 
Corporate bonds   975            975 
Equity securities   141    265        406 
    Total securities available for sale  $307,454   $856   $2,542   $305,768 

 

   December 31, 2016 
       Gross   Gross     
       Unrealized   Unrealized     
   Amortized Cost   Gains   Losses   Fair Value 
Mortgage-backed securities                    
Agencies  $135,054   $793   $957   $134,890 
Collateralized   63,837    61    1,145    62,753 
Collateralized mortgage obligations   19,626    288    104    19,810 
Asset-backed securities   14,866        108    14,758 
Municipals                    
Tax-exempt   67,738        2,983    64,755 
Taxable   18,105    1    430    17,676 
Corporate bonds   983    1        984 
Equity securities   969    848        1,817 
 Total securities available for sale  $321,178   $1,992   $5,727   $317,443 

 

As of September 30, 2017 and December 31, 2016, the Company had available-for-sale securities with a fair value of $60.3 million and $83.0 million, respectively, pledged as collateral for public deposits, borrowings and other depositor requirements.

 

Unrealized Losses

 

The following tables present the fair values and gross unrealized losses aggregated by investment category and length of time and the number of individual securities that have been in a continuous unrealized loss position as of the dates stated:

 

 13 

 

  

       September 30, 2017 
       Less than 12 Months   12 Months or More   Total 
   Number of       Unrealized       Unrealized       Unrealized 
   Securities   Fair Value   Loss   Fair Value   Loss   Fair Value   Loss 
Mortgage-backed securities                                   
Agencies   16   $49,514   $356   $11,389   $139   $60,903   $495 
Collateralized   17    13,199    150    29,956    650    43,155    800 
Collateralized mortgage obligations   7    25,499    176            25,499    176 
Asset-backed securities   2            6,611    75    6,611    75 
Municipals                                   
Tax-exempt   36    8,998    143    8,682    134    17,680    277 
Taxable   10    13,937    82    37,302    637    51,239    719 
Total securities available for sale   88   $111,147   $907   $93,940   $1,635   $205,087   $2,542 

 

       December 31, 2016 
       Less than 12 Months   12 Months or More   Total 
   Number of       Unrealized       Unrealized       Unrealized 
   Securities   Fair Value   Loss   Fair Value   Loss   Fair Value   Loss 
Mortgage-backed securities                                   
Agencies   33   $88,315   $945   $695   $12   $89,010   $957 
Collateralized   19    42,272    1,145            42,272    1,145 
Collateralized mortgage obligations   6    7,216    104            7,216    104 
Asset-backed securities   6    5,443    64    9,315    44    14,758    108 
Municipals                                   
Tax-exempt   44    64,755    2,983            64,755    2,983 
Taxable   9    17,149    430            17,149    430 
Total securities available for sale   117   $225,150   $5,671   $10,010   $56   $235,160   $5,727 

 

Management evaluates investment securities for other-than-temporary impairment ("OTTI") at least quarterly and more frequently when economic or market conditions warrant such an evaluation. In evaluating OTTI, management considers many factors, including: (1) the length of time and the extent to which fair value has been less than cost; (2) the financial condition and near-term prospects of the issuer; (3) whether the market decline was affected by macroeconomic conditions; and (4) whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before its anticipated recovery. The assessment of whether an OTTI decline exists involves a high degree of subjectivity and judgment and is based on the information available to management at a point in time.

 

In instances where an unrealized loss did occur, there was no indication of an adverse change in credit on any of the underlying securities noted in the tables above, and management believes no individual unrealized loss represented an OTTI as of those dates. The Company does not intend to sell, and it is not more likely than not that it will be required to sell, the investment securities before the recovery of their amortized cost basis, which may be at maturity.

 

Maturities of Investment Securities

 

The following table presents the amortized cost and fair value by contractual maturity of investment securities available for sale as of the dates stated. Expected maturities may differ from contractual maturities, as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Securities that are not due at a single maturity date and equity securities that do not have contractual maturities are shown separately.

 

 14 

 

  

   September 30, 2017   December 31, 2016 
   Amortized       Amortized     
   Cost   Fair Value   Cost   Fair Value 
Municipals                
Due in one year or less  $254   $254   $502   $502 
Due after one year but less than five years   14,121    13,950    11,300    11,072 
Due after five years but less than ten years   64,487    63,732    69,900    66,880 
Due after ten years   2,582    2,544    4,141    3,977 
Mortgage-backed securities                    
Agencies   127,298    127,253    135,054    134,890 
Collateralized   63,716    62,984    63,837    62,753 
Collateralized mortgage obligations   27,194    27,059    19,626    19,810 
Corporate Bonds   975    975    983    984 
Asset-backed securities   6,686    6,611    14,866    14,758 
Equity securities   141    406    969    1,817 
Total securities available for sale  $307,454   $305,768   $321,178   $317,443 

 

Restricted Equity Securities

 

The Company's holds stock in the Federal Home Loan Bank ("FHLB") in the amount of $7.4 million and $10.1 million at September 30, 2017 and December 31, 2016, respectively. FHLB stock is generally viewed as a long-term investment and as a restricted investment security, as it is required to be held in order to access FHLB advances (i.e., borrowings). The Company earns dividends from its investment in FHLB stock, and for the three months and nine months ended September 30, 2017 recorded an annualized dividend rate of 5.16% and 5.05%, respectively. The investment in FHLB stock is carried at cost as there is no active market or exchange for the stock other than the FHLB or member institutions.  

 

The Company holds stock in the Federal Reserve Bank ("FRB") in the amount of $14.5 million and $14.0 million at September 30, 2017 and December 31, 2016, respectively. FRB stock is generally viewed as a long-term investment and as a restricted investment security, as it is required to be held to effect membership in the Federal Reserve. It is carried at cost as there is not an active market or exchange for the stock other than the FRB or member institutions.

 

The remaining restricted stock held by the Company, in the amount of $178 thousand at September 30, 2017 and December 31, 2016, is stock in other banks with which the Bank conducts or has the ability to conduct correspondent activity. These investments are also carried at cost as there is no readily available market for these securities.

 

 15 

 

  

NOTE 6 - Loans and Allowance for Loan Losses

 

Loans are carried at their unpaid principal amount outstanding net of unamortized fees and origination costs, partial charge-offs, if any, and in the case of acquired loans, unaccreted fair value or purchase accounting adjustments. All lending decisions are based upon a thorough evaluation of the financial strength and credit history of the borrower and the quality and value of the collateral securing the loan.

 

The Company makes owner-occupied real estate ("OORE") loans, which are secured in part by the real estate that is generally the offices or production facilities of the borrower. In some cases, the real estate is not held by the commercial enterprise, rather it is owned by the principals of the business or an entity controlled by the principals. The Company classifies OORE loans as commercial and industrial, as the primary source of repayment of the loan is generally dependent on the financial performance of the commercial enterprise occupying the property, with the real estate being a secondary source of repayment.

 

The Company held guaranteed student loans ("GSLs"), which were originated under the Federal Family Education Loan Program ("FFELP"), authorized by the Higher Education Act of 1965, as amended. Pursuant to the FFELP, the student loans are substantially guaranteed by a guaranty agency and reinsured by the U.S. Department of Education. The Company had an agreement with a third-party servicer of student loans to provide all day-to-day operational requirements for the servicing of the loans. The GSLs carried a nearly 98% guarantee of principal and accrued interest. The GSLs were acquired in the Legacy Xenith Merger, and the carrying amount of the GSLs approximated the guaranteed portion of the loans. In each of the three-month periods ended June 30, 2017 and March 31, 2017, the Company sold a portion of the GSLs. In both periods, the proceeds from the sales were $9.9 million, and the gain on the sales was $19 thousand, which is recorded in noninterest income on the Company's consolidated statements of income. At September 30, 2017, GSLs are reported as held for sale in the consolidated balance sheet, as the Company had entered into an agreement to sell the remaining GSLs subsequent to September 30, 2017. Such sale occurred in October 2017, and the Company recorded a gain of $214 thousand on the sale.

 

The following table presents the Company's composition of loans as of the dates stated:

 

   September 30, 2017   December 31, 2016 
Commercial & Industrial  $766,506   $895,952 
Construction   274,441    257,712 
Commercial real estate   655,001    585,727 
Residential real estate   390,071    405,291 
Consumer   336,832    274,008 
Guaranteed student loans       44,043 
Deferred loan fees and related costs   1,289    1,323 
Total loans  $2,424,140   $2,464,056 

 

As of September 30, 2017 and December 31, 2016, the Company had $585.4 million and $625.0 million, respectively, of loans pledged to the FRB and the FHLB as collateral for borrowings.

 

Acquired Loans

 

Acquired loans are initially recorded at estimated fair value as of the date of acquisition; therefore, any related allowance for loan losses is not carried over or established at acquisition. The difference between contractually required amounts receivable and the acquisition date fair value of loans that are not deemed credit-impaired at acquisition is accreted (recognized) into income over the life of the loan either on a straight-line basis or based on the underlying principal payments on the loan. Any deterioration in credit quality subsequent to acquisition for loans with remaining discounts is reflected in the allowance for loan losses at such time the remaining purchase accounting adjustment (discount) for the acquired loans is inadequate to cover the allowance needs of these loans.

 

 16 

 

  

Loans acquired with evidence of credit deterioration since origination and for which it is probable at the date of acquisition that contractually required principal and interest payments will not be collected are accounted for under ASC 310-30, Loans and Debt Securities Acquired with Deteriorated Credit Quality ("ASC 310-30"). A portion of the loans acquired in the Legacy Xenith Merger were deemed to be purchased credit-impaired loans qualifying for accounting under ASC 310-30.

 

In applying ASC 310-30 to acquired loans, the Company must estimate the amount and timing of cash flows expected to be collected. The estimation of the amount and timing of expected cash flows to be collected requires significant judgment, including default rates, the amount and timing of prepayments, and the value and timing of the liquidation of underlying collateral, in addition to other factors.

 

ASC 310-30 requires periodic re-evaluation of expected cash flows for purchased credit-impaired loans subsequent to acquisition date. Decreases in expected cash flows attributable to credit will generally result in an impairment charge to earnings such that the accretable yield remains unchanged. Increases in expected cash flows will result in an increase in the accretable yield recognized in income over the remaining period of expected cash flows from the loan. Any impairment charge recorded as a result of a re-evaluation is recorded as an increase in the allowance for loan and lease losses.

 

Acquired loans for which the amount or timing of cash flows cannot be predicted are accounted for under the cost recovery method, whereby principal and interest payments received reduce the carrying value of the loan until such amount has been received. Amounts received in excess of the carrying value are reported in interest income.

 

 17 

 

  

Allowance for Loan Losses

 

The following table presents the allowance for loan loss activity by loan type for the periods stated:

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2017   2016   2017   2016 
Balance at beginning of period  $17,027   $22,903   $21,940   $23,157 
Charge-offs:                    
Commercial & Industrial   186    84    5,199    1,160 
Construction   6        61    635 
Commercial real estate   21        743    663 
Residential real estate   1,355    340    1,690    2,234 
Consumer   8    3    671    45 
Overdrafts   52    43    162    106 
Total charge-offs   1,628    470    8,526    4,843 
Recoveries:                    
Commercial & Industrial   418    173    840    2,833 
Construction   37    167    732    911 
Commercial real estate   95    11    398    341 
Residential real estate   116    253    613    603 
Consumer   183    7    221    23 
Overdrafts   17    1    38    1 
 Total recoveries   866    612    2,842    4,712 
Net charge-offs   762    (142)   5,684    131 
Provision for loan losses       10,685    9    10,704 
Balance at end of period  $16,265   $33,730   $16,265   $33,730 

 

The Company had recorded no allowance for loan losses on its GSL portfolio, as the carrying amount of the portfolio approximated the portion of the loans subject to federal guarantee.

 

 18 

 

  

The following tables present the allowance for loan lease losses, with the amount independently and collectively evaluated for impairment, and loan balances by loan type as of the dates stated:

 

   September 30, 2017 
       Individually Evaluated   Collectively Evaluated 
   Total Amount   for Impairment   for Impairment 
Allowance for loan losses applicable to:               
Purchased credit-impaired loans               
Commercial & Industrial  $   $   $ 
Construction            
Commercial real estate            
Residential real estate   9    9     
Consumer            
Total purchased credit-impaired loans   9    9     
Originated and other purchased loans               
Commercial & Industrial   2,381    172    2,209 
Construction   1,613    240    1,373 
Commercial real estate   3,320    654    2,666 
Residential real estate   3,126    1,306    1,820 
Consumer   1,876        1,876 
Unallocated qualitative   3,940        3,940 
Total originated and other purchased loans   16,256    2,372    13,884 
Total allowance for loan losses  $16,265   $2,381   $13,884 
Loan balances applicable to:               
Purchased credit-impaired loans               
Commercial & Industrial  $758   $758   $ 
Construction   935    935     
Commercial real estate   987    987     
Residential real estate   1,618    1,618     
Consumer   45    45     
Total purchased credit-impaired loans   4,343    4,343     
Originated and other purchased loans               
Commercial & Industrial   765,748    15,643    750,105 
Construction   273,506    7,030    266,476 
Commercial real estate   654,014    7,284    646,730 
Residential real estate   388,453    11,312    377,141 
Consumer   336,787    213    336,574 
Deferred loan fees and related costs   1,289        1,289 
Total originated and other purchased loans   2,419,797    41,482    2,378,315 
Total loans  $2,424,140   $45,825   $2,378,315 

 

 19 

 

 

 

   December 31, 2016 
       Individually Evaluated   Collectively Evaluated 
   Total Amount   for Impairment   for Impairment 
Allowance for loan losses applicable to:               
Purchased credit-impaired loans               
Commercial & Industrial  $   $   $ 
Construction            
Commercial real estate            
Residential real estate            
Consumer            
Total purchased credit-impaired loans            
Originated and other purchased loans               
Commercial & Industrial   5,816    3,327    2,489 
Construction   1,551    161    1,390 
Commercial real estate   2,410    734    1,676 
Residential real estate   5,205    1,275    3,930 
Consumer   1,967    606    1,361 
Guaranteed student loans            
Unallocated qualitative   4,991        4,991 
Total originated and other purchased loans   21,940    6,103    15,837 
Total allowance for loan losses  $21,940   $6,103   $15,837 
Loan balances applicable to:               
Purchased credit-impaired loans               
Commercial & Industrial  $897   $897   $ 
Construction   992    992     
Commercial real estate   1,090    1,090     
Residential real estate   2,122    2,122     
Consumer   55    55     
Total purchased credit-impaired loans   5,156    5,156     
Originated and other purchased loans               
Commercial & Industrial   895,055    24,052    871,003 
Construction   256,720    7,982    248,738 
Commercial real estate   584,637    9,184    575,453 
Residential real estate   403,169    12,637    390,532 
Consumer   273,953    1,551    272,402 
Guaranteed student loans   44,043        44,043 
Deferred loan fees and related costs   1,323        1,323 
Total originated and other purchased loans   2,458,900    55,406    2,403,494 
Total loans  $2,464,056   $60,562   $2,403,494 

 

 20 

 

  

The following tables present the loans that were individually evaluated for impairment as of the dates and for the periods stated. The tables present those loans with and without an allowance and various additional data.

 

   September 30, 2017 
   Recorded Investment   Unpaid Principal
Balance
   Related Allowance 
With no related allowance recorded:               
Purchased credit-impaired loans               
Commercial & Industrial  $758   $1,099   $ 
Construction   935    1,389     
Commercial real estate   987    1,402     
Residential real estate   1,571    2,067     
Consumer   45    80     
Originated and other purchased loans               
Commercial & Industrial   10,871    12,398     
Construction   6,559    15,513     
Commercial real estate   5,026    5,745     
Residential real estate   5,518    7,015     
Consumer   213    235     
With an allowance recorded:               
Purchased credit-impaired loans               
Commercial & Industrial            
Construction            
Commercial real estate            
Residential real estate   47    65    9 
Consumer            
Originated and other purchased loans               
Commercial & Industrial   4,772    4,772    172 
Construction   471    471    240 
Commercial real estate   2,258    2,258    654 
Residential real estate   5,794    5,832    1,306 
Consumer            
Total loans individually evaluated for impairment  $45,825   $60,341   $2,381 

 

 21 

 

  

   December 31, 2016 
   Recorded Investment   Unpaid Principal
Balance
   Related Allowance 
With no related allowance recorded:               
Purchased credit-impaired loans               
Commercial & Industrial  $897   $1,298   $ 
Construction   992    1,448     
Commercial real estate   1,090    1,520     
Residential real estate   2,122    2,989     
Consumer   55    92     
Originated and other purchased loans               
Commercial & Industrial   12,809    14,185     
Construction   7,078    16,327     
Commercial real estate   7,131    9,214     
Residential real estate   7,038    7,816     
Consumer   8    28     
With an allowance recorded:               
Purchased credit-impaired loans               
Commercial & Industrial            
Construction            
Commercial real estate            
Residential real estate            
Consumer            
Originated and other purchased loans               
Commercial & Industrial   11,243    16,297    3,327 
Construction   904    1,054    161 
Commercial real estate   2,053    2,053    734 
Residential real estate   5,599    5,631    1,275 
Consumer   1,543    1,546    606 
Total loans individually evaluated for impairment  $60,562   $81,498   $6,103 

 

 22 

 

  

   Three Months Ended September 30, 
   2017   2016 
   Average
Recorded
Investment
   Interest Income
Recognized
   Average
Recorded
Investment
   Interest Income
Recognized
 
With no related allowance recorded:                    
Purchased credit-impaired loans                    
Commercial & Industrial  $769   $   $878   $1 
Construction   944        1,826    6 
Commercial real estate   998        1,608    12 
Residential real estate   1,659    5    2,368    6 
Consumer   46    1    17     
Originated and other purchased loans                    
Commercial & Industrial   11,221    58    12,664    74 
Construction   6,568    70    5,395    48 
Commercial real estate   4,409    52    8,007    68 
Residential real estate   6,159    15    6,396    1 
Consumer   222        14     
With an allowance recorded:                    
Purchased credit-impaired loans                    
Commercial & Industrial                
Construction                
Commercial real estate                
Residential real estate   48             
Consumer                
Originated and other purchased loans                    
Commercial & Industrial   4,808    47    16,391    51 
Construction   488        10,297    3 
Commercial real estate   2,260    12    2,229    3 
Residential real estate   5,823    31    5,148    43 
Consumer           1,393     
Total loans individually evaluated for impairment  $46,422   $291   $74,631   $316 

 

 23 

 

  

   Nine Months Ended September 30, 
   2017   2016 
   Average
Recorded
Investment
   Interest Income
Recognized
   Average
Recorded
Investment
   Interest Income
Recognized
 
With no related allowance recorded:                    
Purchased credit-impaired loans                    
Commercial & Industrial  $801   $   $878   $1 
Construction   963        1,826    6 
Commercial real estate   1,031        1,608    12 
Residential real estate   1,951    25    2,368    6 
Consumer   51    3    17     
Originated and other purchased loans                    
Commercial & Industrial   11,321    173    12,839    224 
Construction   6,760    210    5,478    144 
Commercial real estate   5,199    155    8,101    204 
Residential real estate   6,217    46    6,466    4 
Consumer   223        14     
With an allowance recorded:                    
Purchased credit-impaired loans                    
Commercial & Industrial                
Construction                
Commercial real estate                
Residential real estate   51             
Consumer                
Originated and other purchased loans                    
Commercial & Industrial   4,894    140    16,721    153 
Construction   496        14,485    7 
Commercial real estate   2,319    37    2,316    9 
Residential real estate   5,850    94    5,345    131 
Consumer           1,412     
Total loans individually evaluated for impairment  $48,127   $883   $79,874   $901 

 

The following table presents accretion of acquired loan discounts for the periods stated. The amount of accretion recognized in the periods is dependent on discounts recorded to reflect acquired loans at their estimated fair values as of the date of the Legacy Xenith Merger. The amount of accretion recognized within a period is based on many factors, including, among other factors, loan prepayments and curtailments; therefore, amounts recognized are subject to volatility.

 

 24 

 

  

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2017   2016   2017   2016 
Balance at beginning of period  $6,472   $   $9,030   $ 
Additions       11,584        11,584 
Accretion (1)   (594)   (1,509)   (2,630)   (1,509)
Disposals (2)   (201)       (723)    
Balance at end of period  $5,677   $10,075   $5,677   $10,075 

  

(1) Accretion amounts are reported in interest income.

(2) Disposals represent the reduction of purchase accounting adjustments (loan discounts) due to the resolution of acquired loans at amounts less than the contractually-owed receivable.

 

Of the $12.5 million fair value adjustment recorded as part of the Legacy Xenith Merger, $3.2 million was related to $9.9 million of purchased credit-impaired loans. As of September 30, 2017, the remaining carrying value and fair value adjustment on the purchased credit-impaired loans were $4.3 million and $1.8 million, respectively.

 

Management believes the Company's allowance for loan losses as of September 30, 2017 is adequate to absorb losses inherent in the portfolio. Although various data and information sources are used to establish the allowance for loan losses, future adjustments to the allowance for loan losses may be necessary, if conditions, circumstances or events are substantially different from the assumptions used in making the assessments. Such adjustments to original estimates, as necessary, are made in the period in which these factors and other relevant considerations indicate that loss levels may vary from previous estimates. In addition, the allowance is subject to regulatory examinations and determination as to adequacy, which may take into account such factors as the methodology used to calculate the allowance and the size of the allowance in comparison to peer banks identified by regulatory agencies. Such agencies may require the Company to recognize additions to the allowance for loan losses based on their judgments about information available at the time of the examinations.

 

Impaired Loans

 

Total impaired loans were $45.8 million and $60.6 million at September 30, 2017 and December 31, 2016, respectively. Collateral dependent impaired loans were $36.7 million and $50.2 million at September 30, 2017 and December 31, 2016, respectively, and are measured at the estimated fair value of the underlying collateral less costs to sell. Impaired loans for which no allowance is provided totaled $32.5 million and $39.2 million at September 30, 2017 and December 31, 2016, respectively. Loans written down to their estimated fair value of collateral less costs to sell account for $7.3 million and $8.1 million of the impaired loans for which no allowance has been provided as of September 30, 2017 and December 31, 2016, respectively.  

 

Nonperforming Assets

 

Nonperforming assets consist of nonaccrual loans and other real estate owned and repossessed assets. As of September 30, 2017, the Company had no loans other than GSLs, which are reported as held for sale, that were past due greater than 90 days and accruing interest.

 

 25 

 

  

The following table presents nonperforming assets as of the dates stated:

 

   September 30, 2017   December 31, 2016 
Purchased credit-impaired loans:          
Commercial & Industrial  $758   $897 
Construction   935    992 
Commercial real estate   987    1,090 
Residential real estate   1,318    1,549 
Consumer   33    39 
Total purchased credit-impaired loans   4,031    4,567 
Originated and other purchased loans:          
Commercial & Industrial   5,782    11,805 
Construction   2,027    2,830 
Commercial real estate   2,257    3,686 
Residential real estate   6,692    7,931 
Consumer   213    1,551 
Total originated and other purchased loans   16,971    27,803 
Total nonaccrual loans   21,002    32,370 
Other real estate owned   4,817    5,345 
Total nonperforming assets  $25,819   $37,715 

 

The following table presents a reconciliation of nonaccrual loans to impaired loans as of the dates stated:

 

   September 30, 2017   December 31, 2016 
Nonaccrual loans  $21,002   $32,370 
TDRs on accrual   24,513    27,603 
Impaired loans on accrual   310    589 
Total impaired loans  $45,825   $60,562 

 

 The following table presents a rollforward of nonaccrual loans for the period stated:

 

   Commercial &
Industrial
   Construction   Commercial
real estate
   Residential real
estate
   Consumer   Total 
Balance at December 31, 2016  $12,702   $3,822   $4,776   $9,480   $1,590   $32,370 
Transfers in   4,169    468    1,294    5,005    491    11,427 
Transfers to other real estate owned       (75)       (630)       (705)
Charge-offs   (5,196)   (62)   (742)   (1,688)   (838)   (8,526)
Payments   (4,343)   (1,191)   (1,587)   (2,569)   (980)   (10,670)
Return to accrual   (748)       (497)   (1,632)   (17)   (2,894)
Loan type reclassification   (44)           44         
Balance at September 30, 2017  $6,540   $2,962   $3,244   $8,010   $246   $21,002 

 

 26 

 

  

 Age Analysis of Past Due Loans

 

The following presents an age analysis of loans as of the dates stated:

 

   September 30, 2017 
       30-89 days   90+ days   Total   Total 
   Current   Past Due   Past Due   Past Due   Loans 
Purchased credit-impaired loans:                         
Commercial & Industrial  $169   $   $589   $589   $758 
Construction   860        75    75    935 
Commercial real estate   611        376    376    987 
Residential real estate   1,200    87    331    418    1,618 
Consumer   12        33    33    45 
Total purchased credit-impaired loans   2,852    87    1,404    1,491    4,343 
Originated and other purchased loans:                         
Commercial & Industrial   760,670    567    4,511    5,078    765,748 
Construction   271,539    161    1,806    1,967    273,506 
Commercial real estate   651,756        2,258    2,258    654,014 
Residential real estate   380,395    3,485    4,573    8,058    388,453 
Consumer   336,474    105    208    313    336,787 
Guaranteed student loans                    
Deferred loan fees and related costs   1,289                1,289 
Total originated and other purchased loans   2,402,123    4,318    13,356    17,674    2,419,797 
Total loans  $2,404,975   $4,405   $14,760   $19,165   $2,424,140 

 

 27 

 

  

   December 31, 2016 
       30-89 days   90+ days   Total   Total 
   Current   Past Due   Past Due   Past Due   Loans 
Purchased credit-impaired loans:                         
Commercial & Industrial  $145   $11   $741   $752   $897 
Construction   774    181    37    218    992 
Commercial real estate   1,090                1,090 
Residential real estate   1,261    297    564    861    2,122 
Consumer   16        39    39    55 
Total purchased credit-impaired loans   3,286    489    1,381    1,870    5,156 
Originated and other purchased loans:                         
Commercial & Industrial   883,531    1,714    9,810    11,524    895,055 
Construction   254,058    53    2,609    2,662    256,720 
Commercial real estate   580,355    2,911    1,371    4,282    584,637 
Residential real estate   395,579    5,124    2,466    7,590    403,169 
Consumer   272,147    1,630    176    1,806    273,953 
Guaranteed student loans   30,909    5,562    7,572    13,134    44,043 
Deferred loan fees and related costs   1,323                1,323 
Total originated and other purchased loans   2,417,902    16,994    24,004    40,998    2,458,900 
Total loans  $2,421,188   $17,483   $25,385   $42,868   $2,464,056 

 

 28 

 

  

Credit Quality

 

The following tables present information about the credit quality of the loan portfolio using the Company's internal rating system as an indicator as of the dates stated:

  

   September 30, 2017 
       Special         
   Pass   Mention   Substandard   Total 
Purchased credit-impaired loans:                    
Commercial & Industrial  $   $   $758   $758 
Construction           935    935 
Commercial real estate           987    987 
Residential real estate       203    1,415    1,618 
Consumer           45    45 
Total purchased credit-impaired loans       203    4,140    4,343 
Originated and other purchased loans:                    
Commercial & Industrial   745,020    14,351    6,377    765,748 
Construction   264,271    6,781    2,454    273,506 
Commercial real estate   644,781    3,083    6,150    654,014 
Residential real estate   354,201    19,961    14,291    388,453 
Consumer   331,937    4,625    225    336,787 
Deferred loan fees and related costs   1,289            1,289 
Total originated and other purchased loans   2,341,499    48,801    29,497    2,419,797 
Total loans  $2,341,499   $49,004   $33,637   $2,424,140 

 

 29 

 

 

 

   December 31, 2016 
       Special         
   Pass   Mention   Substandard   Total 
Purchased credit-impaired loans:                    
Commercial & Industrial  $   $   $897   $897 
Construction           992    992 
Commercial real estate           1,090    1,090 
Residential real estate           2,122    2,122 
Consumer           55    55 
Total purchased credit-impaired loans           5,156    5,156 
Originated and other purchased loans:                    
Commercial & Industrial   873,180    9,391    12,484    895,055 
Construction   247,335    6,460    2,925    256,720 
Commercial real estate   571,781    3,689    9,167    584,637 
Residential real estate   366,940    21,646    14,583    403,169 
Consumer   270,919    1,467    1,567    273,953 
Guaranteed student loans   44,043            44,043 
Deferred loan fees and related costs   1,323            1,323 
Total originated and other purchased loans   2,375,521    42,653    40,726    2,458,900 
Total loans  $2,375,521   $42,653   $45,882   $2,464,056 

  

Troubled Debt Restructuring ("TDRs")

 

Loans meeting the criteria to be classified as TDRs are included in impaired loans. The following table presents the number of and recorded investment in loans classified as TDRs by management as of the dates stated:

 

   September 30, 2017   December 31, 2016 
   Number of
Contracts
   Recorded
Investment
   Number of
Contracts
   Recorded
Investment
 
Commercial & Industrial   9   $10,636    13   $13,067 
Construction   5    5,065    5    5,225 
Commercial real estate   6    5,026    7    5,498 
Residential real estate   11    4,763    14    5,082 
Consumer                
Total   31   $25,490    39   $28,872 

 

Of TDRs, amounts totaling $24.5 million were accruing and $977 thousand were nonaccruing at September 30, 2017, and $27.6 million were accruing and $1.3 million were nonaccruing at December 31, 2016. Loans classified as TDRs that are on nonaccrual status at the time of the restructuring generally remain on nonaccrual status for approximately six months before management considers whether such loans may return to accrual status. Loans classified as TDRs in nonaccrual status may be returned to accrual status after a period of performance under which the borrower demonstrates the ability and willingness to repay the loan in accordance with the modified terms. For the nine months ended September 30, 2017, none of the nonaccrual TDRs were returned to accrual status.

 

 30 

 

  

The following table presents a rollforward of accruing and nonaccruing TDRs for the period stated:

 

   Accruing   Nonaccruing   Total 
Balance at December 31, 2016  $27,603   $1,269   $28,872 
Charge-offs       (7)   (7)
Payments   (3,090)   (285)   (3,375)
New TDR designation            
Release TDR designation            
Transfer            
Balance at September 30, 2017  $24,513   $977   $25,490 

 

The following table presents performing and nonperforming loans identified as TDRs, by loan type, as of the dates stated:

 

   September 30, 2017   December 31, 2016 
Performing TDRs:          
Commercial & Industrial  $9,861   $12,247 
Construction   5,002    5,152 
Commercial real estate   5,026    5,498 
Residential real estate   4,624    4,706 
Consumer        
Total performing TDRs   24,513    27,603 
Nonperforming TDRs:          
Commercial & Industrial   775    820 
Construction   63    73 
Commercial real estate        
Residential real estate   139    376 
Consumer        
Total nonperforming TDRs   977    1,269 
Total TDRs  $25,490   $28,872 

 

The allowance for loan losses allocated to TDRs was $850 thousand and $705 thousand at September 30, 2017 and December 31, 2016, respectively. TDR balances charged off were $7 thousand in the nine months ended September 30, 2017.

 

There were no loans designated as TDRs by management during the three and nine months ended September 30, 2017. For the three and nine months ended September 30, 2017, the Company had no loans for which there was a payment default and subsequent movement to nonaccrual status that were modified as TDRs within the previous 12 months. The Company had no commitments to lend additional funds to debtors owing receivables whose terms have been modified in TDRs at September 30, 2017 and December 31, 2016.

 

 31 

 

  

NOTE 7 - Goodwill and Other Intangible Assets

 

Goodwill of $26.9 million and core deposit intangible of $4.0 million were recorded in the allocation of the purchase consideration in the Legacy Xenith Merger. The core deposit intangible is being amortized over approximately eight years on a straight-line basis.

 

The following table presents goodwill and other intangible assets as of the dates stated.

 

   September 30, 2017   December 31, 2016 
Amortizable core deposit intangible:          
Gross amount  $4,006   $4,006 
Accumulated amortization   (613)   (219)
Net core deposit intangible  $3,393   $3,787 
Goodwill  $26,931   $26,931 

 

NOTE 8 - Other Real Estate Owned and Repossessed Assets

 

The following table presents a rollforward of other real estate owned and repossessed assets for the period stated:

 

   Amount 
Balance at December 31, 2016  $5,345 
Transfers in (via foreclosure)   1,304 
Sales   (1,769)
Gain on sales   74 
Impairments   (137)
Balance at September 30, 2017  $4,817 

 

As of September 30, 2017, there were $316 thousand of residential real estate properties included in the balance of other real estate owned and repossessed assets, and the Company held $1.4 million of residential mortgage loans secured by residential real estate properties for which formal foreclosure proceedings were in process.

 

Other real estate owned and repossessed assets are presented net of a valuation allowance. The following table presents an analysis of the valuation allowance on these assets for the periods stated:

 

   September 30, 2017   September 30, 2016 
Balance at beginning of year  $3,031   $9,875 
Impairments   137    1,320 
Charge-offs   (1,776)   (8,137)
Balance at end of period  $1,392   $3,058 

 

 32 

 

  

The following table presents amounts applicable to other real estate owned and repossessed assets included in the consolidated statements of income for the periods stated:

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2017   2016   2017   2016 
Loss (gain) on sales  $(82)  $(52)  $(74)  $(1,208)
Impairments   34    737    137    1,320 
Operating expenses   12    104    147    276 
Total noninterest expense  $(36)  $789   $210   $388 

 

NOTE 9 - Derivative Instruments

 

Derivatives are financial instruments whose value is based on one or more underlying assets. The Company, through GBMI, originated residential mortgage loans for sale into the secondary market on a best efforts basis. In connection with the underwriting process, the Company entered into commitments to lock-in the interest rate of the loan with the borrower prior to funding ("interest rate-lock commitments"). Generally, such interest rate-lock commitments were for periods less than 60 days. These interest rate-lock commitments are considered derivatives. The Company managed its exposure to changes in fair value associated with these interest rate-lock commitments by entering into simultaneous agreements to sell the residential loans to third-party investors shortly after their origination and funding. At September 30, 2017 and December 31, 2016, the Company had loans held for sale of $0 and $9.9 million, respectively, which were reported in assets from discontinued operations on the Company's consolidated balance sheet.

 

Under the contractual relationship in the best efforts method, the Company was obligated to sell the loans only if the loans closed. As a result of the terms of these contractual relationships, the Company was not exposed to changes in fair value nor would it realize gains or losses related to its interest rate-lock commitments due to subsequent changes in interest rates. At September 30, 2017 and December 31, 2016, the Company had interest rate-lock commitments to originate residential mortgage loans (unfunded par amount of loans) on a best efforts basis in the amounts of $0 and $1.4 million, respectively, which were reported as discontinued operations.

 

The Company has derivative financial instruments not designated as hedges and result from a service the Company provides to meet the needs of certain commercial customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Derivative contracts are executed between the Company and certain commercial loan customers with offsetting positions to dealers under a back-to-back swap arrangement enabling the commercial loan customers to effectively exchange variable-rate interest payments under their existing obligations to the Company for fixed-rate interest payments. These derivatives do not meet hedge accounting requirements; therefore, changes in the fair value of both the customer derivative and the offsetting derivative are recognized in net income. For the nine months ended September 30, 2017 and 2016, the Company recorded $941 thousand and $35 thousand, respectively, of income related to its back-to-back interest rate swap program, which were included in other noninterest income on the consolidated statements of income.

 

The Company has minimum collateral requirements with its financial institution counterparties for these back-to-back interest rate swaps that contain provisions, whereby if the Company fails to maintain its status as a well or an adequately capitalized institution, the Company could be required to terminate or fully collateralize the derivative contract. Additionally, if the Company defaults on any of its indebtedness, including default where repayment has not been accelerated by the lender, the Company could also be in default on its derivative obligations. As of September 30, 2017, the Bank had cash and securities in the amount of $3.0 million pledged as collateral under the agreements. If the Company is not in compliance with the terms of the derivative agreements, it could be required to settle its obligations under the agreements at termination value.

 

 33 

 

  

Certain financial instruments, including derivatives, may be eligible for offset in the consolidated balance sheet and/or subject to master netting arrangements. The Company's derivative transactions with financial institution counterparties are generally executed under International Swaps and Derivative Association (ISDA) master agreements, which include right of setoff provisions. In such cases there is generally a legally enforceable right to offset recognized amounts and there may be an intention to settle such amounts on a net basis. However, the Company has not offset financial instruments for financial reporting purposes.

 

The following tables present information about derivatives that are eligible for offset in the consolidated balance sheets as of the dates stated:

 

       Gross   Net Amounts   Gross Amounts     
       Amounts   of Assets   Not Offset in the     
   Gross   Offset in   Presented   Consolidated Balance Sheets     
   Amounts   the   in the             
   of   Consolidated   Consolidated       Cash and Security     
   Recognized   Balance   Balance   Financial   Collateral   Net 
   Assets   Sheets   Sheets   Instruments   Received   Amount 
Derivative assets:                              
September 30, 2017                              
Interest rate swap agreements  $1,813   $   $1,813   $128   $   $1,685 
December 31, 2016                              
Interest rate swap agreements   1,223        1,223    53        1,170 

 

       Gross   Net Amounts   Gross Amounts     
       Amounts   of Liabilities   Not Offset in the     
   Gross   Offset in   Presented   Consolidated Balance Sheets     
   Amounts   the   in the             
   of   Consolidated   Consolidated       Cash and Security     
   Recognized   Balance   Balance   Financial   Collateral   Net 
   Liabilities   Sheets   Sheets   Instruments   Requirement   Amount 
Derivative liabilities:                              
September 30, 2017                              
Interest rate swap agreements  $1,722   $   $1,722   $128   $808   $786 
December 31, 2016                              
Interest rate swap agreements   1,226        1,226    53    341    832 

 

 34 

 

  

NOTE 10 - Income Taxes

 

The provision for income taxes is based upon the results of operations, adjusted for the effect of certain tax-exempt income and non-deductible expenses. Certain items of income and expense are reported in different periods for financial reporting and tax return purposes resulting in temporary differences. The tax effects of these temporary differences are recognized currently in the deferred income tax provision or benefit on the Company's consolidated statement of operations. As of September 30, 2017, the Company had a net deferred tax asset of $148.4 million recorded on its consolidated balance sheets, which is net of a valuation allowance of $780 thousand.

 

The following table presents the federal statutory tax rate reconciled to the Company's effective tax rate from continuing operations for the period stated:

 

   Nine Months Ended September 30, 2017 
   Tax   Rate 
Effective tax rate from continuing operations:          
Income tax at statutory rate  $9,853    35.00%
Tax-exempt income   (750)   (2.66)%
Nondeductible expenses   40    0.14%
Other   (146)   (0.53)%
Income tax provision from continuing operations  $8,997    31.95%

 

Deferred tax assets or liabilities are computed based on the difference between the financial statement and income tax bases of assets and liabilities. These differences will result in deductible or taxable amounts in a future year(s) when the reported amounts of assets or liabilities are recovered or settled. Deferred assets and liabilities are stated at tax rates expected to be in effect in the year(s) the differences reverse. A valuation allowance is recorded against that portion of the deferred tax assets when it is not more likely than not that all or a portion of the asset will be realized.

 

A valuation allowance related to all components of net deferred tax assets was established in 2009 and was adjusted, as necessary, each reporting period. The valuation allowance was established based upon a determination at the time that it was not more likely than not that the deferred tax assets would be fully realized primarily as a result of the significant operating losses experienced by the Company during 2009 and several years thereafter.

 

ASC 740, Accounting for Income Taxes, paragraph 740-10-30-18, states that four possible sources of taxable income may be available under the tax law to realize a tax benefit for deductible temporary differences. In determining the need for a valuation allowance and in accordance with ASC 740-10-30-17, management evaluated all available evidence, both positive and negative, assessing the objectivity of the evidence and giving more weight to that evidence which is more objective than evidence which is subjective. Positive and negative evidence refers to factors affecting the predictability of one or more of the four sources of taxable income.

 

The positive evidence in the third quarter of 2016 included the fact that the Company had been in a positive cumulative pre-tax income position for the previous three years and the Company expected to generate taxable income in future years sufficient to absorb substantially all of its net deferred tax assets. A significant component of the Company's deferred tax asset, as of September 30, 2016, related to federal net operating losses ("NOLs") of approximately $300.0 million, which under current law can be carried forward 20 years.

 

 35 

 

  

Management's estimate of future taxable income is based on internal projections, which consider historical performance, various internal estimates and assumptions, as well as certain external data, all of which, while inherently subject to judgment, management believes to be reasonable. At December 31, 2015, management concluded that the Company did not have sufficient future income to absorb all NOLs and only a portion of the deferred tax asset related to NOLs would be realized, thus releasing only a portion of the valuation allowance ($95.1 million). In the third quarter of 2016, as a result of the Legacy Xenith Merger, management believed the Company had sufficient future income to absorb substantially all of the deferred tax assets, including assets relating to NOLs, and substantially all of the remaining valuation allowance ($60.0 million) was released. The remaining valuation allowance relates to the deferred tax asset resulting from NOLs in the Commonwealth of Virginia, where Xenith Bankshares, Inc. (the parent company) files a standalone tax return. The parent company is not expected to generate taxable income in future periods; therefore, management has concluded that it is not more likely than not that the deferred tax assets of $780 thousand related to these NOLs will be utilized.

 

If actual results differ significantly from the current estimates of future taxable income, even if caused by adverse macro-economic conditions, the valuation allowance may need to be increased for some or all of the Company's net deferred tax assets. An increase to the deferred tax asset valuation allowance could have a material adverse effect on the Company's financial condition and results of operations.

 

NOTE 11 - Borrowings

 

The Bank has secured borrowing facilities with the FHLB and the FRB. As of September 30, 2017, total credit availability under the FHLB facility was $794.7 million, limited to a pledged lendable collateral value of $303.0 million. Under this facility, as of September 30, 2017, there were short-term, non-amortizing borrowings outstanding of $105.0 million. Credit availability under the FRB facility as of September 30, 2017 was $112.8 million, which is also based on pledged collateral value. As of September 30, 2017, the Bank had no borrowings under the FRB facility.

 

Short-term borrowing sources also include lines of credit with eight banks to borrow federal funds up to $153.0 million on an unsecured basis. The lines are uncommitted and can be canceled by the lender at any time. Two of the lines expire within one year; the remaining lines have no stated expiration. At September 30, 2017, no amounts were outstanding under these uncommitted lines of credit. Borrowings under these arrangements bear interest at the prevailing Federal Funds Rate.

 

The Company has four placements of trust preferred securities. In all four trusts, the trust issuer has invested the total proceeds from the sale of the trust preferred securities in junior subordinated deferrable interest debentures issued by the Company. The trust preferred securities pay cumulative cash distributions quarterly at an annual rate, which resets quarterly. The Company has fully and unconditionally guaranteed the trust preferred securities through the combined operation of the debentures and other related documents. The Company's obligation under the guarantee is unsecured and subordinate to other senior and subordinated indebtedness. The trust preferred securities are redeemable only at the Company's discretion, subject to regulatory approval. The aggregate carrying value of these debentures as of September 30, 2017 was $30.6 million, The difference between the par amounts and the carrying amounts of the debentures, which is due to purchase accounting adjustments recorded at the acquisition of Gateway Financial Holdings, Inc. in 2008, is being amortized using the interest method as an adjustment to interest expense. Effective interest rates for the trust preferred securities for the three and nine month periods ended September 30, 2017 were between 7.60% and 8.21% and 7.33% and 8.01%, respectively.

 

In the Legacy Xenith Merger, the Company assumed $8.5 million in aggregate principal amount of Legacy Xenith's outstanding 6.75% subordinated notes due 2025 (the "Subordinated Notes"). The Subordinated Notes bear interest at an annual rate of 6.75%, which is payable quarterly in arrears on March 31, June 30, September 30 and December 31 and qualify as Tier 2 capital for the Company. As of September 30, 2017, the carrying value of the Subordinated Notes, including the remaining fair value adjustment recorded at the Legacy Xenith Merger, was $8.6 million. For the three- and nine-month periods ended September 30, 2017, the effective interest rate, including the amortization of the purchase accounting adjustment, on the Subordinated Notes was 6.40%. As of September 30, 2017, the Company and the Bank, as applicable, were in compliance with all covenants of the Subordinated Notes.

 

 36 

 

  

NOTE 12 - Earnings Per Share

 

The following tables present weighted average basic and diluted shares outstanding and basic and diluted earnings per share for the periods stated. Earnings per share is presented for continuing operations, discontinued operations and total net income attributable to the Company. All stock options were included in the diluted earnings per share calculations for the three and nine months ended September 30, 2017. There were 505,029 and 557,121 stock options not included in the diluted earnings per share calculations for the three and nine months ended September 30, 2016, respectively, because their inclusion would have been antidilutive.

 

   Three Months Ended   Nine Months Ended 
   September 30,
2017
   September 30,
2016
   September
30, 2017
   September 30,
2016
 
Weighted average shares outstanding, basic   23,209,041    21,005,458    23,184,307    18,462,161 
Dilutive effect of warrants   75,718    50,247    72,251    47,263 
Dilutive effect of equity awards   234,593    65,145    218,614    51,191 
Dilutive shares   310,311    115,392    290,865    98,454 
Weighted average shares outstanding, diluted   23,519,351    21,120,850    23,475,172    18,560,615 

 

   Three Months Ended   Nine Months Ended 
   September 30,
2017
   September 30,
2016
   September 30,
2017
   September 30,
2016
 
Net Income:                    
Net income from continuing operations  $7,165   $47,501   $19,156   $50,402 
Net (loss) income from discontinued operations   (7)   363    (68)   1,467 
Net income attributable to Xenith Bankshares  $7,158   $47,864   $19,088   $51,869 
                     
Basic earnings per share:                    
Earnings per share from continuing operations  $0.31   $2.26   $0.83   $2.74 
Earnings per share from discontinued operations  $   $0.02   $   $0.07 
Earnings per share attributable to Xenith Bankshares  $0.31   $2.28   $0.82   $2.81 
                     
Diluted earnings per share:                    
Earnings per share from continuing operations  $0.30   $2.25   $0.82   $2.72 
Earnings per share from discontinued operations  $   $0.02   $   $0.07 
Earnings per share attributable to Xenith Bankshares  $0.30   $2.27   $0.81   $2.79 

 

 37 

 

  

NOTE 13 - Commitments and Contingencies

 

On September 7, 2017, Paul Parshall, a purported shareholder of Xenith Bankshares, filed a putative class action lawsuit (the "Parshall Lawsuit") in the United States District Court for the Eastern District of Virginia against the Company, the current members of the Company's board of directors, and Union on behalf of all of the Company's public shareholders. The plaintiff in the Parshall Lawsuit alleges that Union's registration statement on Form S-4, as amended, filed with the SEC relating to the Union Merger omitted certain material information in violation of Section 14(a) of the Exchange Act and Rule 14a-9 promulgated thereunder, and further that the individual defendants are liable for those omissions under Section 20(a) of the Exchange Act. The relief sought in the Parshall Lawsuit includes preliminary and permanent injunction to prevent the completion of the Union Merger, rescission or rescissory damages if the Union Merger is completed, costs and attorneys' fees. On November 6, 2017, the plaintiff in the Parshall Lawsuit filed a notice of voluntary dismissal, terminating the Parshall Lawsuit without prejudice.

 

On September 19, 2017, Shannon Rowe, a purported shareholder of Xenith Bankshares, also filed a putative class action lawsuit (the "Rowe Lawsuit") in the United States District Court for the Eastern District of Virginia against the Company and the current members of the Company's board of directors. The allegations in the Rowe Lawsuit are similar to the allegations in the Parshall Lawsuit, described above.

 

At this time, it is not possible to predict the outcome of the Rowe Lawsuit or its impact on the Company or the Union Merger. Management believes the claims in the Rowe Lawsuit are without merit, and the Company and its board of directors intend to defend vigorously against them.

 

In addition to the Rowe Lawsuit, in the ordinary course of operations, the Company may become a party to legal proceedings. Based upon information currently available, management believes that any such legal proceedings, in the aggregate, will not have a material adverse effect on the Company's business, financial condition, cash flows, or results of operations.

 

In the normal course of business, the Company has commitments under credit agreements to lend to customers as long as there is no material violation of any condition established in the agreements. These commitments generally have fixed expiration dates or other termination clauses and may require payments of fees. Because many of the commitments may expire without being completely drawn upon, the total commitment amounts do not necessarily represent future cash requirements.

 

Additionally, the Company issues letters of credit, which are conditional commitments to guarantee the performance of customers to third parties. The credit risk involved in issuing letters of credit is the same as that involved in extending loans to customers.

 

These commitments represent outstanding off-balance sheet commitments. The following table presents unfunded loan commitments outstanding as of the dates stated:

 

   September 30, 2017   December 31, 2016 
Commercial lines of credit  $391,645   $372,083 
Construction   172,571    113,364 
Commercial real estate   36,858    44,790 
Residential real estate   91,976    93,981 
Consumer   8,102    11,108 
Letters of credit   24,935    20,476 
Total commitments  $726,087   $655,802 

 

 38 

 

  

NOTE 14 - Fair Value Measurements

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company classifies financial assets and liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. Valuation methodologies for the fair value hierarchy are as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain U.S. Treasury securities that are highly liquid and are actively traded in over-the-counter markets.

 

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments and derivative contracts whose values are determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include values that are determined using pricing models, discounted cash flow methodologies, or similar techniques as well as assets and liabilities for which the determination of fair value requires significant management judgment or estimation.

 

The categorization of an asset or liability within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

Recurring Basis

 

The Company measures or monitors certain of its assets on a fair value basis. Fair value is used on a recurring basis for those assets and liabilities for which an election was made, as well as for certain assets and liabilities in which fair value is the primary basis of accounting. The following tables present the fair value of assets measured and recognized at fair value on a recurring basis in the consolidated balance sheets as of the dates stated:

 

       Fair Value Measurements at Reporting Date Using 
Assets  September 30, 2017   Level 1   Level 2   Level 3 
Investment securities available for sale                    
Mortgage-backed securities                    
Agencies  $127,253   $   $127,253   $ 
Collateralized   62,984        62,984     
Collateralized mortgage obligations   27,059        27,059     
Asset-backed securities   6,611        6,611     
Municipals                    
Tax-exempt   62,799        62,799     
Taxable   17,680        17,680     
Corporate bonds   976        976     
Equity securities   406    307        99 
Total securities available for sale   305,768    307    305,362    99 
Interest rate swaps   1,813        1,813     
Investments in rabbi trust   1,800    1,800         
Total assets  $309,381   $2,107   $307,175   $99 
                     
Liabilities                    
Interest rate swaps  $1,722   $   $1,722   $ 
Total liabilities  $1,722   $   $1,722   $ 

  

 39 

 

 

 

 

       Fair Value Measurements at Reporting Date Using 
Assets  December 31, 2016   Level 1   Level 2   Level 3 
Investment securities available for sale                    
Mortgage-backed securities                    
Agencies  $134,890   $   $134,890   $ 
Collateralized   62,753        62,753     
Collateralized mortgage obligations   19,810        19,810     
Asset-backed securities   14,758        14,758     
Municipals                    
Tax-exempt   64,755        64,755     
Taxable   17,676        17,676     
Corporate bonds   984        984     
Equity securities   1,817    1,718        99 
Total securities available for sale   317,443    1,718    315,626    99 
Derivative loan commitments   126            126 
Interest rate swaps   1,223        1,223     
Investments in rabbi trust   1,804    1,804         
Total assets  $320,596   $3,522   $316,849   $225 
                     
Liabilities                    
Interest rate swaps  $1,226   $   $1,226   $ 
Total liabilities  $1,226   $   $1,226   $ 

 

The following table presents a rollforward of recurring fair value measurements categorized within Level 3 of the fair value hierarchy for the periods stated:

 

   Activity in Level 3   Activity in Level 3 
   Fair Value Measurements   Fair Value Measurements 
   Nine Months Ended September 30, 2017   Year Ended December 31, 2016 
   Investment
Securities
Available for Sale
   Derivative
Loan
Commitments
   Investment
Securities
Available for Sale
   Derivative
Loan
Commitments
 
                     
Beginning of period balance  $99   $126   $99   $1,020 
Unrealized gains included in:                    
Earnings                
Other comprehensive income                
Purchases                
Sales                
Reclassification from level 3 to level 1                
Issuances               470 
Settlements       (126)       (1,364)
End of period balance  $99   $   $99   $126 

 

The Company's policy is to recognize transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer.

 

The following describes the valuation techniques used to estimate fair value for assets and liabilities that are measured on a recurring basis.

 

 40 

 

 

Investment Securities Available for Sale: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly-liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models or quoted prices of securities with similar characteristics. Level 2 securities would include U.S. agency securities, mortgage-backed securities, obligations of states and political subdivisions, and certain corporate, asset-backed and other securities valued using third-party quoted prices in markets that are not active. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy.

 

Interest Rate Swaps: The Company uses observable inputs to determine fair value of its interest rate swaps. The valuation of these instruments is determined using widely accepted valuation techniques that are based on discounted cash flow analysis using the expected cash flows of each derivative over the contractual terms of the derivatives, including the period to maturity and market-based interest rate curves. The fair value of the interest rate swaps is determined using a market standard methodology of netting the discounted future fixed cash receipts and the discounted expected variable cash payments. The variable cash payments were based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. Accordingly, the Company categorizes these financial instruments within Level 2 of the fair value hierarchy.

 

Investments in Rabbi Trust: Assets held by the Company in the rabbi trust consist of readily-marketable securities where quoted prices are available in active markets and are classified as Level 1 securities.

 

Nonrecurring Basis

 

Certain assets, specifically collateral dependent impaired loans and other real estate owned and repossessed assets, are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment and an allowance is established to adjust the asset to its estimated fair value). The adjustments are based on appraisals of underlying collateral or other observable market prices when current appraisals or observable market prices are available. If an appraisal that is less than 12 months old is not available, an existing appraisal or other valuation would be utilized after adjusting it to reflect current market conditions and, as such, may include significant management assumptions and input with respect to the determination of fair value. 

 

The adjustments are based in part upon externally derived statistical data and upon management's knowledge of market conditions and prices of sales of other real estate owned. It is the Company's policy to classify these as Level 3 assets within the fair value hierarchy. Management periodically reviews the adjustments as compared to valuations from updated appraisals and modifies the adjustments accordingly should updated appraisals reflect valuations significantly different than those derived utilizing the adjustments. Management believes the valuations are reasonable for the collateral underlying the loan portfolio; however, while appraisals are indicators of fair value, the amount realized upon the sale of these assets could be significantly different.

 

 

The following tables present the fair value of assets measured and recognized at fair value on a nonrecurring basis in the consolidated balance sheets as of the dates stated:

 

   Assets
Measured at
   Fair Value Measurements at
September 30, 2017 Using
 
   Fair Value   Level 1   Level 2   Level 3 
Impaired loans  $39,541   $   $   $39,541 
Other real estate owned and repossessed assets   4,817            4,817 

 

 41 

 

 

   Assets
Measured at
   Fair Value Measurements at
December 31, 2016 Using
 
   Fair Value   Level 1   Level 2   Level 3 
Impaired loans  $49,378   $   $   $49,378 
Other real estate owned and repossessed assets   5,345            5,345 

  

The following describes the valuation techniques used to estimate fair value for assets that are required to be measured on a nonrecurring basis.

 

Impaired Loans: The majority of the Company's impaired loans are considered collateral dependent. For collateral dependent impaired loans, fair value is measured based upon the estimated fair value of the underlying collateral less costs of disposal or other observable market prices when current appraisals or observable market prices are available. If an appraisal that is less than 12 months old is not available, an existing appraisal or other valuation would be utilized after adjusting it to reflect current market conditions and, as such, may include significant management assumptions and input with respect to the determination of fair value. 

 

Other Real Estate Owned and Repossessed Assets: The fair value of other real estate owned and repossessed assets is based primarily on appraisals of the real estate or other observable market prices. The Company's policy is to have current appraisals of these assets; however, if a current appraisal is not available, an existing appraisal would be utilized after adjusting it to reflect changes in market conditions from the date of the existing appraisal and, as such, may include significant management assumptions and input with respect to the determination of fair value.

 

Significant Unobservable Inputs

 

The following table presents the significant unobservable inputs used to value the Company's significant Level 3 assets as of the date stated. These factors represent the significant unobservable inputs that were used in measurement of fair value.

 

       Significant Unobservable  Significant Unobservable
   Fair Value at   Inputs by  Inputs as of
   September 30, 2017   Valuation Technique  September 30, 2017
Impaired loans   39,541   Appraised value  9%
        Average discounts to reflect current   
        market conditions, estimated ultimate   
        collectability, and estimated costs to sell   
Other real estate owned   4,817   Appraised value  10%
        Weighted average discounts to reflect   
        current market conditions, abbreviated   
        holding period and estimated costs to sell   

 

Other Fair Value Measurements

 

Accounting standards require the disclosure of the estimated fair value of financial instruments that are not recorded at fair value. For the financial instruments that the Company does not record at fair value, estimates of fair value are made at a point in time based on relevant market data and information about the financial instrument. No readily available market exists for a significant portion of the Company's financial instruments. Fair value estimates for these instruments are based on current economic conditions, interest rate risk characteristics and other factors. Many of these estimates involve uncertainties and matters of significant judgment and cannot be determined with precision; therefore, the calculated fair value estimates in many instances cannot be substantiated by comparison to independent markets and, in many cases, may not be realizable in a current sale of the instrument. In addition, changes in assumptions could significantly affect these fair value estimates. The following methods and assumptions were used by the Company in estimating fair value of these financial instruments.

 

 42 

 

 

Cash and Cash Equivalents: Cash and cash equivalents include cash and due from banks, interest-bearing deposits in other banks, and overnight funds sold and due from the FRB. The carrying amount approximates fair value.

 

Investment Securities Available for Sale: Fair values are based on published market prices where available. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flows. Investment securities available for sale are carried at their aggregate fair value.

 

Restricted Equity Securities: These investments are carried at cost. The carrying amount approximates fair value.

 

Loans: To determine the fair values of loans other than those deemed impaired, the Company uses discounted cash flow analyses using discount rates that are similar to the interest rates and terms currently being offered to borrowers of similar terms and credit quality. In valuing acquired loans, the Company also uses valuation techniques that include default rates for similar risk rated loans and estimates of expected cash flows as well as other factors.

 

Interest Receivable and Interest Payable: The carrying amount approximates fair value.

 

Bank-owned Life Insurance: The carrying amount approximates fair value.

 

Deposits: The fair values disclosed for non-maturity deposits such as demand, including money market, and savings accounts are equal to the amount payable on demand at the reporting date (i.e., carrying values). Fair values for certificates of deposit are estimated using discounted cash flows that apply market interest rates on comparable instruments.

 

Borrowings: The fair value of short-term FHLB borrowings approximates the carrying amount. Other borrowings include the Subordinated Notes and the junior subordinated debentures. The fair value of the Subordinated Notes approximates the carrying value. The fair value of the junior subordinated debentures approximates the par value of such borrowings.

 

Commitments to Extend Credit and Standby Letters of Credit: The only amounts recorded for commitments to extend credit and standby letters of credit are the deferred fees arising from these unrecognized financial instruments. These deferred fees are not deemed significant at September 30, 2017 and December 31, 2016, and, as such, the related fair values have not been estimated.

 

 43 

 

 

The following tables present the carrying amounts and fair values of those financial instruments that were not recorded at fair value of have carrying amounts that approximate fair value as of the dates stated:

  

   September 30, 2017 
   Carrying   Fair   Fair Value Measurements at Reporting Date Using 
   Amount   Value   Level 1   Level 2   Level 3 
Financial Assets:                         
Loans, net (1)  $2,407,875   $2,412,741   $   $   $2,412,741 
Financial Liabilities:                         
Deposits   2,605,390    2,603,279        2,603,279     
FHLB borrowings   105,000    105,000        105,000     
Other borrowings   39,197    65,276        65,276     

 

   December 31, 2016 
   Carrying   Fair   Fair Value Measurements at Reporting Date Using 
   Amount   Value   Level 1   Level 2   Level 3 
Financial Assets:                         
Loans, net (1)  $2,442,116   $2,448,581   $   $   $2,448,581 
Financial Liabilities:                         
Deposits   2,571,970    2,573,070        2,573,070     
FHLB borrowings   172,000    172,000        172,000     
Other borrowings   38,813    65,303        65,303     

 

(1) The carrying amount and fair value include impaired loans, and the carrying amount is net of the allowance for loan losses.

 

 44 

 

 

NOTE 15 - Subsequent Events

 

Management has evaluated subsequent events through November 9, 2017, which is the date the consolidated financial statements were available to be issued. There were no subsequent events that required adjustment to or disclosure in the consolidated financial statements.

 

 45